11 employees
Sonnest offers an electrically sensitive imaging agent for assessing and monitoring the perfusion, structure, and function of the heart.
2019
$4M
from 3 investors over 3 rounds
Sonnest, Inc. raised undisclosed on February 2, 2022
Investors: Texas HALO Fund
Sonnest, Inc. raised $4M on March 23, 2021
Investors: Robin Hood Ventures and Texas HALO Fund